JP2013536183A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013536183A5 JP2013536183A5 JP2013523219A JP2013523219A JP2013536183A5 JP 2013536183 A5 JP2013536183 A5 JP 2013536183A5 JP 2013523219 A JP2013523219 A JP 2013523219A JP 2013523219 A JP2013523219 A JP 2013523219A JP 2013536183 A5 JP2013536183 A5 JP 2013536183A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- alkyl
- alkenyl
- wounds
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 33
- 125000000217 alkyl group Chemical group 0.000 claims 14
- 229910052760 oxygen Inorganic materials 0.000 claims 12
- 229910052799 carbon Inorganic materials 0.000 claims 10
- 229910052717 sulfur Inorganic materials 0.000 claims 9
- 206010072170 Skin wound Diseases 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 7
- 230000037303 wrinkles Effects 0.000 claims 6
- 206010052428 Wound Diseases 0.000 claims 5
- 208000027418 Wounds and injury Diseases 0.000 claims 5
- 239000000556 agonist Substances 0.000 claims 5
- 150000001412 amines Chemical class 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 4
- 125000005429 oxyalkyl group Chemical group 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 231100000241 scar Toxicity 0.000 claims 4
- 208000032544 Cicatrix Diseases 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 230000037387 scars Effects 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000000732 arylene group Chemical group 0.000 claims 2
- 210000004709 eyebrow Anatomy 0.000 claims 2
- 150000004820 halides Chemical class 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000005549 heteroarylene group Chemical group 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000005020 hydroxyalkenyl group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- -1 oxyalkenyl Chemical group 0.000 claims 2
- 230000036573 scar formation Effects 0.000 claims 2
- 208000009043 Chemical Burns Diseases 0.000 claims 1
- 208000034693 Laceration Diseases 0.000 claims 1
- 206010040844 Skin exfoliation Diseases 0.000 claims 1
- 208000002847 Surgical Wound Diseases 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 229940125904 compound 1 Drugs 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 230000000994 depressogenic effect Effects 0.000 claims 1
- 206010020718 hyperplasia Diseases 0.000 claims 1
- 230000002390 hyperplastic effect Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 230000002980 postoperative effect Effects 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 230000037373 wrinkle formation Effects 0.000 claims 1
- HTNXVEJEYFOLQV-CURYUGHLSA-N C[C@H](c1ccccc1)/N=C(\c1c(C)cc[s]1)/[U]c(cc1)ccc1F Chemical compound C[C@H](c1ccccc1)/N=C(\c1c(C)cc[s]1)/[U]c(cc1)ccc1F HTNXVEJEYFOLQV-CURYUGHLSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36923210P | 2010-07-30 | 2010-07-30 | |
| US61/369,232 | 2010-07-30 | ||
| US41911510P | 2010-12-02 | 2010-12-02 | |
| US61/419,115 | 2010-12-02 | ||
| PCT/US2011/045833 WO2012016109A2 (en) | 2010-07-30 | 2011-07-29 | Compounds and methods for skin repair |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013536183A JP2013536183A (ja) | 2013-09-19 |
| JP2013536183A5 true JP2013536183A5 (OSRAM) | 2014-09-18 |
Family
ID=44543791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013523219A Pending JP2013536183A (ja) | 2010-07-30 | 2011-07-29 | 皮膚修復のための化合物及び方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20120136011A1 (OSRAM) |
| EP (1) | EP2598140B1 (OSRAM) |
| JP (1) | JP2013536183A (OSRAM) |
| KR (1) | KR20130130694A (OSRAM) |
| CN (1) | CN103068382A (OSRAM) |
| AR (1) | AR082428A1 (OSRAM) |
| AU (1) | AU2011282549A1 (OSRAM) |
| BR (1) | BR112013002319A2 (OSRAM) |
| CA (1) | CA2806982A1 (OSRAM) |
| CL (1) | CL2013000308A1 (OSRAM) |
| CO (1) | CO6680670A2 (OSRAM) |
| MX (1) | MX2013001227A (OSRAM) |
| NZ (1) | NZ607306A (OSRAM) |
| PH (1) | PH12013500205A1 (OSRAM) |
| RU (1) | RU2013108394A (OSRAM) |
| SG (1) | SG187653A1 (OSRAM) |
| TW (1) | TW201210601A (OSRAM) |
| WO (1) | WO2012016109A2 (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8697458B2 (en) | 2009-04-22 | 2014-04-15 | Shat-R-Shield, Inc. | Silicone coated light-emitting diode |
| US8894992B2 (en) * | 2010-08-19 | 2014-11-25 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8741281B2 (en) * | 2010-08-19 | 2014-06-03 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| EP2605762A1 (en) * | 2010-08-19 | 2013-06-26 | Allergan, Inc. | Compositions comprising adipose tissue and a pge2 analogue and their use in the treatment of a soft tissue condition |
| US8889123B2 (en) * | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8883139B2 (en) * | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
| US8900571B2 (en) * | 2010-08-19 | 2014-12-02 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8926963B2 (en) * | 2010-08-19 | 2015-01-06 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US9005605B2 (en) * | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8697057B2 (en) * | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US20120142684A1 (en) * | 2010-12-02 | 2012-06-07 | Allergan, Inc. | Compounds and methods for skin repair |
| US20140142092A1 (en) * | 2012-11-16 | 2014-05-22 | Allergan, Inc. | Compounds and methods for skin repair |
| CA2890034A1 (en) * | 2012-11-16 | 2014-05-22 | Allergan, Inc. | Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations |
| JP6749234B2 (ja) * | 2013-09-27 | 2020-09-02 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | 皮膚修復のための化合物及び方法 |
| RU2625548C1 (ru) * | 2015-04-29 | 2017-07-14 | Жанна Юрьевна Юсова | Способ коррекции возрастных изменений кожи лица |
| RU2663391C1 (ru) * | 2018-01-30 | 2018-08-03 | Игорь Николаевич Бондаренко | Способ эстетической коррекции мягких тканей лица |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| TWI249520B (en) * | 1998-07-15 | 2006-02-21 | Ono Pharmaceutical Co | 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient |
| EP1114816A4 (en) * | 1998-09-14 | 2002-09-04 | Ono Pharmaceutical Co | SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES- $ g (V) AND MEDICINAL PRODUCTS CONTAINING THEM AS ACTIVE INGREDIENT |
| JP4618548B2 (ja) * | 1999-11-24 | 2011-01-26 | 小野薬品工業株式会社 | 骨量低下疾患治療剤 |
| US7608637B2 (en) * | 2001-07-23 | 2009-10-27 | Ono Pharmaceutical Co., Ltd. | Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as the active ingredient |
| US20040058313A1 (en) * | 2002-04-24 | 2004-03-25 | Abreu Marcio Marc | Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
| ES2393321T3 (es) * | 2002-10-10 | 2012-12-20 | Ono Pharmaceutical Co., Ltd. | Promotores de la producción de factores de reparación endógenos |
| US7855226B2 (en) * | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| AU2004211936B2 (en) * | 2003-02-11 | 2008-09-11 | Allergan, Inc. | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| US6875787B2 (en) | 2003-02-11 | 2005-04-05 | Allergan, Inc. | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| WO2006016695A1 (ja) * | 2004-08-10 | 2006-02-16 | Ono Pharmaceutical Co., Ltd. | Ｅｐ４アゴニストを含有してなる高カリウム血症の予防および／または治療剤 |
| JP2006321737A (ja) * | 2005-05-18 | 2006-11-30 | Ono Pharmaceut Co Ltd | Ｅｐ４アゴニストを含有する神経変性疾患の予防、治療および／または進展抑制剤 |
| JP2007023028A (ja) * | 2005-06-16 | 2007-02-01 | Ono Pharmaceut Co Ltd | 内耳疾患治療剤 |
| US20070232660A1 (en) * | 2006-04-04 | 2007-10-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
| US7439372B2 (en) * | 2006-05-03 | 2008-10-21 | Allergan, Inc. | Therapeutic compounds |
| JP5069752B2 (ja) * | 2006-12-15 | 2012-11-07 | グラクソ グループ リミテッド | Ｅｐ４受容体アゴニストとしてのベンズアミド誘導体 |
| EP2465506A1 (en) * | 2006-12-18 | 2012-06-20 | Allergan, Inc. | Methods and compositions for treating gastrointestinal disorders |
| EP2147672A4 (en) * | 2007-05-08 | 2011-11-02 | Nat University Corp Hamamatsu University School Of Medicine | CYTOTOXIC T CELL ACTIVATOR WITH AN EP4 AGONIST |
| GB0810615D0 (en) * | 2008-06-10 | 2008-07-16 | Glaxo Group Ltd | Novel pharmaceutical |
-
2011
- 2011-07-29 WO PCT/US2011/045833 patent/WO2012016109A2/en not_active Ceased
- 2011-07-29 PH PH1/2013/500205A patent/PH12013500205A1/en unknown
- 2011-07-29 EP EP11744157.6A patent/EP2598140B1/en not_active Not-in-force
- 2011-07-29 NZ NZ60730611A patent/NZ607306A/en not_active IP Right Cessation
- 2011-07-29 TW TW100127126A patent/TW201210601A/zh unknown
- 2011-07-29 CA CA2806982A patent/CA2806982A1/en not_active Abandoned
- 2011-07-29 KR KR1020137004837A patent/KR20130130694A/ko not_active Withdrawn
- 2011-07-29 BR BR112013002319A patent/BR112013002319A2/pt not_active IP Right Cessation
- 2011-07-29 SG SG2013007430A patent/SG187653A1/en unknown
- 2011-07-29 AR ARP110102761A patent/AR082428A1/es unknown
- 2011-07-29 AU AU2011282549A patent/AU2011282549A1/en not_active Abandoned
- 2011-07-29 RU RU2013108394/15A patent/RU2013108394A/ru not_active Application Discontinuation
- 2011-07-29 MX MX2013001227A patent/MX2013001227A/es not_active Application Discontinuation
- 2011-07-29 JP JP2013523219A patent/JP2013536183A/ja active Pending
- 2011-07-29 US US13/194,078 patent/US20120136011A1/en not_active Abandoned
- 2011-07-29 CN CN2011800404387A patent/CN103068382A/zh active Pending
-
2013
- 2013-01-30 CL CL2013000308A patent/CL2013000308A1/es unknown
- 2013-02-26 CO CO13038986A patent/CO6680670A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013536183A5 (OSRAM) | ||
| JP2013544842A5 (OSRAM) | ||
| RU2013108394A (ru) | Соединения и способы восстановления кожи | |
| RU2013129262A (ru) | Соединения и способы для восстановления кожи | |
| BR112017020132A2 (pt) | métodos para promover o crescimento capilar ou prevenir a perda de cabelo em um indivíduo e para preparar uma composição, e, composição | |
| RU2014113663A (ru) | Композиции кожного наполнителя для лечения мелких морщин | |
| EA201792559A1 (ru) | Фармацевтические композиции для местного применения | |
| MX2022007351A (es) | Derivados de 3-(5-metoxi-1-oxoisoindolin-2-il)piperidin-2,6-diona y usos de los mismos. | |
| JP2016525102A5 (OSRAM) | ||
| JP2014511891A5 (OSRAM) | ||
| JP2019510034A5 (OSRAM) | ||
| PH12016501357A1 (en) | Pharmaceutical preparation containing pyridylamino acetic acid compound | |
| CN113825754A (zh) | 包括甲基和三氟甲基的双取代磺酰胺类选择性bcl-2抑制剂 | |
| MX2020012336A (es) | Formulacion farmaceutica. | |
| EP4410833A3 (en) | Compositions and methods for treating fatty tissue buildup | |
| JP2016510048A (ja) | 毛髪処理の方法 | |
| CN1679480A (zh) | 毛发化妆品 | |
| JP2011046708A5 (OSRAM) | ||
| JP2016514150A5 (OSRAM) | ||
| RU2014128387A (ru) | Ингибиторы рi3к для лечения фиброзных заболеваний | |
| RU2015154741A (ru) | Ингибитор хориоретинальных нарушений | |
| TW201204405A (en) | Hair cosmetic composition | |
| JP2015537028A5 (OSRAM) | ||
| JP2015537028A (ja) | 皮膚修復のための組成物および方法 | |
| TW201632191A (zh) | 一種用於促進傷口癒合或預防、減少傷口疤痕生成的醫藥組合物 |